The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis

Published:2017 Issue:3 Volume:56 Page:165-169
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Tokuhira Michihide¹,Tabayashi Takayuki¹,Tanaka Yuka¹,Takahashi Yasuyuki¹,Kimura Yuta¹,Tomikawa Tatsuki¹,Anan-Nemoto Tomoe¹,Momose Shuju²,Higashi Morihiro²,Okuyama Ayumi³,Watanabe Reiko¹,Amano Koichi³,Tamaru Jun-ichi²,Kizaki Masahiro¹

Affiliation:

1. Department of Hematology, Saitama Medical Center, Saitama Medical University

2. Department of Pathology, Saitama Medical Center, Saitama Medical University

3. Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/56/3/56_165/_pdf

Reference15 articles.

1. 1 Swerdlow SH, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn. IARC: Lyon, 2008

2. 2 Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med. 312: 818-22, 1985

3. 3 Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe D, Bombardier C. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis. BMJ. 353:i1777, 2016

4. 4 Paulus HE. The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis. Arthritis Rheum. 33:113-120, 1990

5. 5 Tokuhira M, Watanabe R, Nemoto T, Sagawa M, Tomikawa T, Tamaru J, et al. Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis. Leuk Lymphoma. 53:616-623, 2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Complex Relationship between Mechanisms Underlying Inflammatory Bowel Disease, Its Treatment, and the Risk of Lymphomas: A Comprehensive Review;International Journal of Molecular Sciences;2024-04-11

2. The first case of methotrexate-associated lymphoproliferative disorder in the sacrum: a case report;BJR|Case Reports;2023-12-13

3. Pathological Vertebral Fracture Arising From Methotrexate-Associated Lymphoproliferative Disorder in a Patient With Systemic Lupus Erythematosus;Cureus;2023-06-07

4. A case of classic Hodgkin lymphoma arising after remission of methotrexate-associated follicular lymphoma;Journal of Clinical and Experimental Hematopathology;2023

5. Methotrexate-Associated Lymphoproliferative Disease of the Thoracic Spine Misdiagnosed as Metastatic Spinal Tumor: A Case Report;Cureus;2022-08-04